DK0885010T3 - Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyle - Google Patents

Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyle

Info

Publication number
DK0885010T3
DK0885010T3 DK97907981T DK97907981T DK0885010T3 DK 0885010 T3 DK0885010 T3 DK 0885010T3 DK 97907981 T DK97907981 T DK 97907981T DK 97907981 T DK97907981 T DK 97907981T DK 0885010 T3 DK0885010 T3 DK 0885010T3
Authority
DK
Denmark
Prior art keywords
sicam
adhesion molecule
amount
drug containing
intercellular adhesion
Prior art date
Application number
DK97907981T
Other languages
Danish (da)
English (en)
Inventor
Eugene J Mcnally
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21757501&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0885010(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0885010T3 publication Critical patent/DK0885010T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK97907981T 1996-03-06 1997-03-04 Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyle DK0885010T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1294496P 1996-03-06 1996-03-06
PCT/US1997/003263 WO1997032596A1 (en) 1996-03-06 1997-03-04 Intercellular adhesion molecule powder formulation

Publications (1)

Publication Number Publication Date
DK0885010T3 true DK0885010T3 (da) 2003-09-15

Family

ID=21757501

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97907981T DK0885010T3 (da) 1996-03-06 1997-03-04 Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyle

Country Status (8)

Country Link
US (1) US6365343B1 (de)
EP (1) EP0885010B1 (de)
JP (1) JP2000507221A (de)
AT (1) ATE242001T1 (de)
CA (1) CA2244894A1 (de)
DE (1) DE69722594T2 (de)
DK (1) DK0885010T3 (de)
WO (1) WO1997032596A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4493594B2 (ja) * 2003-03-04 2010-06-30 田辺三菱製薬株式会社 粉末経鼻投与製剤
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
GB2420707A (en) * 2004-10-11 2006-06-07 Nasaleze Patents Ltd Compositions for intranasal administration
KR20100059859A (ko) * 2007-09-11 2010-06-04 몬도바이오테크 래보래토리즈 아게 치료제로서의 ｃ형 나트륨이뇨 펩티드 단독 또는 뉴로펩티드 ａｆ와의 배합물의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362531B1 (de) * 1988-09-01 1999-11-10 Bayer Corporation Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US5235049A (en) * 1989-01-24 1993-08-10 Molecular Therapeutics, Inc. Nucleic acid sequences encoding a soluble molecule (SICAM-1) related to but distinct from ICAM-1
CA2008368C (en) * 1989-01-24 2003-04-08 Jeffrey Greve Soluble molecule related to but distinct from icam-1
DK0745852T3 (da) * 1989-03-16 2002-10-14 Blood Res Center Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
WO1991018010A1 (en) * 1990-05-15 1991-11-28 Swinburne Limited Inhibition of viral infection using intercellular adhesion molecule-1-like peptides and/or analogues thereof
GB9414966D0 (en) * 1994-07-26 1994-09-14 Danbiosyst Uk Pharmaceutical compositions for the nasal administration of antiviral agents
US5879712A (en) 1995-06-07 1999-03-09 Sri International Method for producing drug-loaded microparticles and an ICAM-1 dosage form so produced

Also Published As

Publication number Publication date
CA2244894A1 (en) 1997-09-12
ATE242001T1 (de) 2003-06-15
EP0885010A1 (de) 1998-12-23
JP2000507221A (ja) 2000-06-13
US6365343B1 (en) 2002-04-02
WO1997032596A1 (en) 1997-09-12
DE69722594D1 (de) 2003-07-10
EP0885010B1 (de) 2003-06-04
DE69722594T2 (de) 2004-04-29

Similar Documents

Publication Publication Date Title
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
NO984376D0 (no) Mikrosfµrer av polysakkarid for administrering av medikamenter til lungene
BR9803300A (pt) Formulação farmacêutica.
MD1813B2 (en) Purified cyclodextrin derivatives of sulphoalkyl ethers or mixtures thereof, clathrate complex of cyclodextrin derivatives with medicamental content and pharmaceutical composition
AU9062998A (en) Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
SE9700135D0 (sv) New formulation
GB2332147A (en) Therapeutically active compositions
EP0679390A3 (de) Aufsprühbare pharmazeutische Zubereitungen für die topische Anwendung
NZ505919A (en) Nasal solutions
IS2789B (is) Lyfjablöndur sem innihalda mónóamínoxídasa B hemla
DK0460062T3 (da) Huperzin A-analoger
IS5110A (is) Ný lyfjablanda til innöndunar með eðlisþyngd í lausu sem er frá 0,28 til 0,38 g/ml, sem inniheldur búdesóníð
ID28510A (id) Formulasi oral yang baru untuk agonis atau antagonis 5-ht4
PT975348E (pt) Composicoes de tibolona estabilizadas
NO20005332L (no) 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding
DK0885010T3 (da) Pulverformigt lægemiddel indeholdende intercellulært adhæsionsmolekyle
NO20012351L (no) Farmasoytisk sammensetning for modifisert frigjoring av insulinsensibiliserende middel
CA2417935A1 (en) Anti-inflammatory medicament
ATE353224T1 (de) Abgabeeinrichtung für eine zusammensetzung einer pharmazeutisch wirksamen substanz
HUP0000882A2 (hu) NMDA (N-metil-D-aszpartát) antagonista hatású indolszármazékok, valamint a vegyületeket tartalmazó gyógyszerkészítmények
AU7470098A (en) Antithrombotic agents
TR200102087T2 (tr) Yeni morfolinbenzamid tuzları
EP1022017A3 (de) Kosmetische oder pharmazeutische Zubereitungen für die topische Verabreichung mit verbesserter Stabilität
ATE194498T1 (de) Wasserfreies mittel auf lactulosebasis